Citations

Mayo Clinic

Showing 10 of 108599 citations.

Artificial Intelligence Can Define and Predict the “Optimal Observed Outcome” After Anterior Shoulder Instability Surgery: An Analysis of 200 Patients With 11‐Year Mean Follow‐Up
Till, Sara E., Lu, Yining , Reinholz, Anna K., Boos, Alexander M. , Krych, Aaron J. , Okoroha, Kelechi R. , Camp, Christopher L. , Lu, Yining , Camp, Christopher L. , Krych, Aaron J , Boos, Alexander

Arthroscopy, Sports Medicine, and Rehabilitation | July 22, 2023 | Volume: 5 | Issue: 4 | Pages: No page available

10.1016/j.asmr.2023.100773 | PMID 37520500 Get It

Purpose To use unsupervised machine learning clustering to define the “optimal observed outcome” after surgery for anterior shoulder instability (ASI) and to identify predictors for achieving it. Methods Medical records, images, and operative reports were reviewed for patients <40 years old undergoing surgery for ASI. Four unsupervised machine learning clustering algorithms partitioned subjects into “optimal observed outcome” or “suboptimal outcome” based on combinations of actually observed outcomes. Demographic, clinical, and treatment variables were compared between groups using descriptive statistics and Kaplan‐Meier survival curves. Variables were assessed for prognostic value through multivariate stepwise logistic regression. Results Two hundred patients with a mean follow‐up of 11 years were included. Of these, 146 (64%) obtained the “optimal observed outcome,” characterized by decreased: postoperative pain (23% vs 52%; P < 0.001), recurrent instability (12% vs 41%; P < 0.001), revision surgery (10% vs 24%; P = 0.015), osteoarthritis (OA) (5% vs 19%; P = 0.005), and restricted motion (161° vs 168°; P = 0.001). Forty‐one percent of patients had a “perfect outcome,” defined as ideal performance across all outcomes. Time from initial instability to presentation (odds ratio [OR] = 0.96; 95% confidence interval [CI], 0.92‐0.98; P = 0.006) and habitual/voluntary instability (OR = 0.17; 95% CI, 0.04‐0.77; P = 0.020) were negative predictors of achieving the “optimal observed outcome.” A predilection toward subluxations rather than dislocations before surgery (OR = 1.30; 95% CI, 1.02‐1.65; P = 0.030) was a positive predictor. Type of surgery performed was not a significant predictor. Conclusions After surgery for ASI, 64% of patients achieved the “optimal observed outcome” defined as minimal postoperative pain, no recurrent instability or OA, low revision surgery rates, and increased range of motion, of whom only 41% achieved a “perfect outcome.” Positive predictors were shorter time to presentation and predilection toward preoperative subluxations over dislocations. Level of Evidence Level IV, retrospective cohort.
Personalised therapy in follicular lymphoma – is the dial turning?
Linton, Kim , Specht, Lena , Pavlovsky, Astrid , Thompson, Carrie A. , Kimby, Eva , Jong, Daphne de , Nastoupil, Loretta J. , Casulo, Carla , Sarkozy, Clémentine , Linton, Kim M , de Jong, Daphne , Cottereau, Anne-Ségolène , Casulo, Carla , Sarkozy, Clémentine , Okosun, Jessica , Nastoupil, Loretta J , Specht, Lena

Hematological Oncology | July 22, 2023 | Volume: 42 | Issue: 6 | Pages: No page available

10.1002/hon.3205 | PMID 37482955 Get It

Abstract Follicular lymphoma is the most common indolent lymphoma accounting for approximately 20%–25% of all new non‐Hodgkin lymphoma diagnoses in western countries. Whilst outcomes are mostly favorable, the spectrum of clinical phenotypes includes high‐risk groups with significantly inferior outcomes. This review discusses recent updates in risk stratification and treatment approaches from upfront treatment for limited and advanced stage follicular lymphoma to the growing options for relapsed, refractory disease with perspectives on how to approach this from a personalized lens. Notable gaps remain on how one can precisely and prospectively select optimal treatment for patients based on varying risks, with an anticipation that an increased understanding of the biology of these different phenotypes and increasing refinement of imaging‐ and biomarker‐based tools will, in time, allow these gaps to be closed.
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review
Brake, Donald R., Yaman, Reena , Camargo, Alyssa, Marks, Lisa , Maddux, Jacob T., Ochkur, Sergei I. , Rank, Matthew A. , Yaman, Reena N, Camargo, Alyssa R, Marks, Lisa A , Brake, Donald L.

Allergy and Asthma Proceedings | July 22, 2023 | Volume: 44 | Issue: 4 | Pages: 229-236

10.2500/aap.2023.44.230022 | PMID 37480203 Get It

Background: Pollen is a key source of aeroallergens responsible for allergic rhinitis, conjunctivitis, and asthma. Objective: The goal of this scoping review was to summarize current available literature on the factors that affect pollen counts, allergenicity, and thresholds that induce symptoms in individuals who were sensitized. Methods: Several databases showed no published articles with a similar scope as of January 2022. A search of these data bases yielded 373 articles for assessment. These were then reviewed for relevance, and articles were selected to demonstrate the breadth of available data on pollen counts, allergenicity, and thresholds that induce symptoms in individuals who were sensitized. Additional articles were identified through examination of bibliographies of search-identified articles. Results: Several environmental factors have shown a correlation with pollen counts and allergen load, including the distance from the source, wind characteristics, pollen size, terrain, urban environments, air composition (particulate matter, CO2 levels, ozone, NO2), and weather conditions (humidity, thunderstorms, precipitation). Pollen thresholds at which symptoms were induced varied by study, pollen type, symptom, disease, and location. In addition, there was heterogeneity in study designs, threshold definition, and outcome measures. Conclusion: This scoping review demonstrates the plethora of variables that influence the relationship between pollen and the symptoms of allergic diseases. Analysis of the available data sheds light on the complex interaction between environmental and biologic factors that affect pollen's role in allergic diseases and provides guidance on multiple areas for further investigation.
Color-Changing Reflection Hologram for Quality Assurance of Therapeutic Ultrasound Systems
Mikulchyk, Tatsiana , Walsh, John , Naydenova, Izabela , Cody, Dervil , Browne, Jacinta , Cody, Dervil , Walsh, John, Browne, Jacinta E.

ACS Applied Materials & Interfaces | July 22, 2023 | Volume: 15 | Issue: 30 | Pages: 36792-36803

10.1021/acsami.3c06139 | PMID 37480156 Get It

Sedation and shivering management after cardiac arrest
Geller, Bram J. , Maciel, Carolina B. , May, Teresa , Jentzer, Jacob C. , Jentzer, Jacob C

European Heart Journal: Acute Cardiovascular Care | July 22, 2023 | Volume: 12 | Issue: 8 | Pages: 518-524

10.1093/ehjacc/zuad087 | PMID 37479475 Get It

Abstract Management of sedation and shivering during targeted temperature management (TTM) after cardiac arrest is limited by a dearth of high-quality evidence to guide clinicians. Data from general intensive care unit (ICU) populations can likely be extrapolated to post-cardiac arrest patients, but clinicians should be mindful of key differences that exist between these populations. Most importantly, the goals of sedation after cardiac arrest are distinct from other ICU patients and may also involve suppression of shivering during TTM. Drug metabolism and clearance are altered considerably during TTM when a low goal temperature is used, which can delay accurate neuroprognostication. When neuromuscular blockade is used to prevent shivering, sedation should be deep enough to prevent awareness and providers should be aware that this can mask clinical manifestations of seizures. However, excessively deep or prolonged sedation is associated with complications including delirium, infections, increased duration of ventilatory support, prolonged ICU length of stay, and delays in neuroprognostication. In this manuscript, we review sedation and shivering management best practices in the post-cardiac arrest patient population.
51. Dynamic Seeding versus Microinjection of Adipose-derived Mesenchymal Stem Cells to Acellular Nerve Allograft Reconstructions
Bedar, Meiwand , Pulos, Nicholas , Shin, Alexander Y.

Plastic and Reconstructive Surgery - Global Open | July 21, 2023 | Volume: 11 | Issue: 5S | Pages: 32-33

10.1097/01.gox.0000937800.92362.dc Get It

76. Measuring the Effect of Glabellar Paralysis on Facial Expression of Emotion Using an Artificial Intelligence Application
Hebel, Nathan , Boonipat, Thanapoom , Stotland, Mitchell A.

Plastic and Reconstructive Surgery - Global Open | July 21, 2023 | Volume: 11 | Issue: 5S | Pages: 47-48

10.1097/01.gox.0000937896.63554.b7 Get It

SP11. Gene Expressions of Fgf7 and Postn in Canine Chordae Tendineae and Their Possible Relations to Tenogenesis in Chordae Tendineae and Potential Effects on Flexor Tenocyte Biology
Wan, Rou , Ren, Ye , Yu, Yinxian, Reisdorf, Ramona L., Moran, Steven L. , Zhao, Chunfeng , Gingery, Anne

Plastic and Reconstructive Surgery - Global Open | July 21, 2023 | Volume: 11 | Issue: 5S | Pages: 126-126

10.1097/01.gox.0000938388.68998.93 Get It

Pharmacists’ role in supporting the return of over 10,000 preemptive pharmacogenomics results: The Mayo Clinic experience
Mitaly, Serena, Wright, Jessica , Melik, Razan El, Matey, Eric T. , Melik, Razan M. El , El Melik, Razan, Matey, Eric, Wright, Jessica A , El Melik, Razan M

American Journal of Health-System Pharmacy | July 21, 2023 | Volume: 80 | Issue: 23 | Pages: 1733-1742

10.1093/ajhp/zxad159 | PMID 37478473 Get It

Abstract Purpose To develop a pharmacist-driven, exploratory pharmacogenomics implementation model with the goal of creating a process for pharmacists to interpret pharmacogenomics results from RIGHT 10K Study samples and provide electronic consults to providers. Summary A train-the-trainer model program was initiated whereby pharmacogenomics pharmacists developed a documentation template and a quick reference guide as a standard guide to train other pharmacists. Pharmacists completed electronic consults (e-consults) reviewing pharmacogenomics results, with reference to drug-gene interactions, for patients with “semi-urgent” and “clinically actionable” results, defined as those indicating a potential for gene-drug interactions to cause major harm and those indicating a potential for an adverse drug reaction or reduced efficacy, respectively. Outcomes measured included the number of consults over time, number and role of pharmacists involved, average time to complete e-consults over time, and gene-drug pairs for semi-urgent consults per month. A total of 395 pharmacists were trained. The total number of e-consults completed was 2,843: 61 semi-urgent and 2,782 clinically actionable consults. The average time spent per consult was 24 minutes, and the average number of e-consults per pharmacist was 7. CYP2C19-clopidogrel was the most common gene-drug pair targeted in semi-urgent consults. Conclusion Pharmacy leaders planning to implement similar pharmacogenomics programs can utilize this data to estimate hiring needs for future pharmacogenomics implementation, while also considering the potential additional cost of developing resources.
How I treat non-transfusion-dependent β-thalassemia
Saliba, Antoine N. , Taher, Alì , Taher, Ali T. , Saliba, Antoine N. , Taher, Ali T , Saliba, Antoine N , Saliba, Antoine N , Taher, Ali T.

Blood | July 21, 2023 | Volume: 142 | Issue: 11 | Pages: 949-960

10.1182/blood.2023020683 | PMID 37478396 Get It

AbstractThe intricate interplay of anemia and iron overload under the pathophysiological umbrella of ineffective erythropoiesis in non-transfusion-dependent β-thalassemia (NTDT) results in a complex variety of clinical phenotypes that are challenging to diagnose and manage. In this article, we use a clinical framework rooted in pathophysiology to present 4 common scenarios of patients with NTDT. Starting from practical considerations in the diagnosis of NTDT, we delineate our strategy for the longitudinal care of patients who exhibit different constellations of symptoms and complications. We highlight the use of transfusion therapy and novel agents, such as luspatercept, in the patient with anemia-related complications. We also describe our approach to chelation therapy in the patient with iron overload. Although tackling every specific complication of NTDT is beyond the scope of this article, we touch on the management of the various morbidities and multisystem manifestations of the disease.